Literature DB >> 16096410

High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice.

Cory Schlesinger1, David G Bostwick, Kenneth A Iczkowski.   

Abstract

In earlier studies, prostate cancer (PCa) has been reported to appear in 21% to 48% of subsequent biopsies for isolated high-grade prostatic intraepithelial neoplasia (PIN) and in 34% to 60% for isolated atypical small acinar proliferation suspicious for, but not diagnostic of, malignancy (ASAP). We report results of follow-up biopsies in a recent cohort of community practice patients who underwent biopsy for PSA abnormalities. The study group consisted of 336 men with initial diagnoses of PIN (n = 204), ASAP (n = 78), or both lesions (n = 54) who underwent at least one repeat biopsy. Mean follow-up intervals in months were 6.0 for PIN, 3.8 for ASAP, and 4.9 for PIN/ASAP. Follow-up PCa detection rates were 23%, 37%, and 33%, respectively. The predictive value of ASAP was significantly higher than that for PIN (P = 0.0188). In 23 PIN studies with chronologic midpoints in the early 1990s, follow-up PCa was detected in a mean of 36% of cases, whereas this value was 21% after the year 2000. In 13 ASAP studies, mean PCa detection on follow-up was 45% until 1996 and 39% from 1997 to present. PIN/ASAP predicted PCa in 33% of cases in our study, similar to ASAP alone (P = 0.65) and had a mean predictive value of 44% in the literature. Factors that may account for the decline in PIN predictive values include: 1) extended biopsy techniques that yield higher rates of initial cancer detection, 2) lower detection rate for the remaining small cancers that may accompany PIN, and 3) remaining PIN cases may lack concomitant cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16096410     DOI: 10.1097/01.pas.0000168178.48535.0d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  [Prostate biopsy - an unending story].

Authors:  G Mikuz
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

2.  Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials.

Authors:  Naoto Kuroda; Kazunobu Katto; Masato Tamura; Tomoyuki Shiotsu; Shoichiro Nakamura; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

3.  Multifocal high-grade prostatic intraepithelial neoplasia is still a significant risk factor for adenocarcinoma.

Authors:  John R Srigley; Jennifer L Merrimen; Glenn Jones; Munir Jamal
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

4.  The role of image guided biopsy targeting in patients with atypical small acinar proliferation.

Authors:  Dima Raskolnikov; Soroush Rais-Bahrami; Arvin K George; Baris Turkbey; Nabeel A Shakir; Chinonyerem Okoro; Jason T Rothwax; Annerleim Walton-Diaz; M Minhaj Siddiqui; Daniel Su; Lambros Stamatakis; Pingkun Yan; Jochen Kruecker; Sheng Xu; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  J Urol       Date:  2014-08-20       Impact factor: 7.450

5.  Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.

Authors:  Juan-Miguel Mosquera; Sven Perner; Elizabeth M Genega; Martin Sanda; Matthias D Hofer; Kirsten D Mertz; Pamela L Paris; Jeff Simko; Tarek A Bismar; Gustavo Ayala; Rajal B Shah; Massimo Loda; Mark A Rubin
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

6.  High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.

Authors:  Nermina Obralic; Benjamin Kulovac
Journal:  Bosn J Basic Med Sci       Date:  2011-11       Impact factor: 3.363

7.  Pathologic results of radical prostatectomies in patients with simultaneous atypical small acinar proliferation and prostate cancer.

Authors:  Kwang Ho Kim; Yun Beom Kim; Jeong Kee Lee; Yoon Jung Kim; Tae Young Jung
Journal:  Korean J Urol       Date:  2010-06-21

Review 8.  Testosterone replacement therapy and prostate cancer: a word of caution.

Authors:  Timothy C Brand; Edith Canby-Hagino; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

9.  Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.

Authors:  Eric P Rahrmann; Lara S Collier; Todd P Knutson; Meghan E Doyal; Sheri L Kuslak; Laura E Green; Rita L Malinowski; Laura Roethe; Keiko Akagi; Michelle Waknitz; Wei Huang; David A Largaespada; Paul C Marker
Journal:  Cancer Res       Date:  2009-04-28       Impact factor: 12.701

10.  Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience.

Authors:  Paras B Singh; Caroline M Nicholson; Narasimhan Ragavan; Rosemary A Blades; Francis L Martin; Shyam S Matanhelia
Journal:  BMC Urol       Date:  2009-05-27       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.